Abstract
Chiral compounds in which biological activity resides in only one of the enantiomers are, increasingly, being demanded in enantiomerically pure form. The use of biocatalysts for production of epoxides as chiral intermediates in the synthesis of these compounds has realistic commercial prospects, but also presents formidable technical problems.
Original language | English |
---|---|
Pages (from-to) | 256-261 |
Number of pages | 6 |
Journal | Trends in Biotechnology |
Volume | 10 |
Issue number | C |
DOIs | |
Publication status | Published - 1 Jan 1992 |
Funding
The financial and technical support of work on direct epoxidation (ICI Bioproducts and SERC) and kinetic resolution (CEC and Andeno/DSM) is gratefully acknowledged.
ASJC Scopus subject areas
- Biotechnology
- Bioengineering